Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
KeyCorp heads into its October 20 Q3 print with a bullish options lean, a wall of analyst target cuts, and the Bank of Nova Scotia sitting on the register as a Schedule 13D filer, three signals that pull in different directions.
Options positioning has shifted further toward calls since the previous note published October 8. The put/call ratio now stands at 0.67, sitting just above its 20-day average of 0.66 with a near-zero z-score, meaning the call-heavy skew from last week has settled into what is now a relatively stable baseline. The 52-week low on the PCR is 0.65, reached just this week, so the options market remains close to its most call-favoured reading of the year. That sits awkwardly against a stock that has fallen 7.9% over the past month to $19.99, a level that leaves it around 25% below the consensus analyst price target of $25.10. Borrow conditions lend no ammunition to bears: share availability is extraordinarily loose, with roughly 51 shares available for every one already borrowed, and borrowing cost has barely moved from 0.37%.
The analyst community is constructive but noticeably less enthusiastic than it was three months ago. UBS trimmed its target from $27 to $25 this month while holding its Buy, and JP Morgan cut from $24.50 to $23 at Neutral. TD Cowen reinstated coverage on October 8 with a Buy at $23. The directional message is consistent: the bull case rests on the Scotiabank capital injection, commercial loan growth, and a credible path toward 15%-plus return on tangible common equity by 2027. The bear case is less dramatic and more grinding: middle-market credit quality can deteriorate quietly, NIM expansion depends on rate assumptions that keep shifting, and geographic concentration across Ohio, New York, and Washington creates pockets of vulnerability a broader-based bank would not carry. Most analysts have not abandoned the stock; they have repriced the time it takes to get where they want it to go.
The FDIC call report data published for Q2 shows KeyCorp's insured bank charters reported their largest second quarter for both total deposits ($158.5 billion) and net loans and leases ($110.4 billion) since at least 2024. The FDIC dataset covering US banks has not yet been tested as a leading indicator against KeyCorp's reported figures, so no reading on the current quarter is available, and these figures cannot be extended into a forecast. What they confirm is that the balance sheet entered the second half of 2026 in a structurally stronger position than any recent comparable period.
Scotiabank's position is the single most newsworthy ownership fact on this ticker. The Bank of Nova Scotia filed a Schedule 13D, an activist-intent filing, in January 2025 and currently holds around 14.8% of shares outstanding, making it far and away the largest single holder. The 13D classification carries legal weight: it signals that Scotiabank's stake is held with an intent beyond passive investment. The stake has edged down slightly from the filing level, and the standard caveat applies: positions are as last disclosed around the 5% threshold. No further filing has appeared to indicate the stake has fallen below 5%. State Street added over 4.2 million shares in Q3, and T. Rowe Price has reduced its position substantially since its 2025 filing.
The October 20 print will test whether KeyCorp's deposit and loan growth has translated into the kind of NIM expansion and fee income momentum needed to convince analysts that the recovery timeline is intact rather than still being pushed out.
See the live data behind this article on ORTEX.
Open KEY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
